Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth.

Bailey ST, Miron PL, Choi YJ, Kochupurakkal B, Maulik G, Rodig SJ, Tian R, Foley KM, Bowman T, Miron A, Brown M, Iglehart JD, Debajit KB.

Mol Cancer Res. 2014 Mar;12(3):408-420. doi: 10.1158/1541-7786.MCR-13-0206-T. Epub 2013 Dec 6.

2.

HIF-prolyl hydroxylases and cardiovascular diseases.

Sen Banerjee S, Thirunavukkarasu M, Tipu Rishi M, Sanchez JA, Maulik N, Maulik G.

Toxicol Mech Methods. 2012 Jun;22(5):347-58. doi: 10.3109/15376516.2012.673088. Review.

PMID:
22424133
3.

Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease.

Malireddy S, Kotha SR, Secor JD, Gurney TO, Abbott JL, Maulik G, Maddipati KR, Parinandi NL.

Antioxid Redox Signal. 2012 Jul 15;17(2):327-39. doi: 10.1089/ars.2012.4600. Epub 2012 Apr 17. Review.

4.

Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview.

Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, Maulik G.

Toxicol Mech Methods. 2012 Jun;22(5):330-5. doi: 10.3109/15376516.2012.666648. Epub 2012 Mar 17. Review.

PMID:
22394340
5.

Novel role of NADPH oxidase in ischemic myocardium: a study with Nox2 knockout mice.

Thirunavukkarasu M, Adluri RS, Juhasz B, Samuel SM, Zhan L, Kaur A, Maulik G, Sanchez JA, Hager J, Maulik N.

Funct Integr Genomics. 2012 Aug;12(3):501-14. doi: 10.1007/s10142-011-0256-x. Epub 2011 Oct 29.

PMID:
22038056
6.

Cardioprotective efficacy of a novel antioxidant mix VitaePro against ex vivo myocardial ischemia-reperfusion injury.

Adluri RS, Thirunavukkarasu M, Zhan L, Maulik N, Svennevig K, Bagchi M, Maulik G.

Cell Biochem Biophys. 2013 Nov;67(2):281-6. doi: 10.1007/s12013-011-9300-7.

PMID:
21960420
7.

Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.

Adluri RS, Thirunavukkarasu M, Dunna NR, Zhan L, Oriowo B, Takeda K, Sanchez JA, Otani H, Maulik G, Fong GH, Maulik N.

Antioxid Redox Signal. 2011 Oct 1;15(7):1789-97. doi: 10.1089/ars.2010.3769. Epub 2011 Apr 8.

8.

Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice.

Adluri RS, Thirunavukkarasu M, Zhan L, Akita Y, Samuel SM, Otani H, Ho YS, Maulik G, Maulik N.

J Mol Cell Cardiol. 2011 Jan;50(1):239-47. doi: 10.1016/j.yjmcc.2010.11.002. Epub 2010 Nov 11.

9.

Second generation sequencing of the mesothelioma tumor genome.

Bueno R, De Rienzo A, Dong L, Gordon GJ, Hercus CF, Richards WG, Jensen RV, Anwar A, Maulik G, Chirieac LR, Ho KF, Taillon BE, Turcotte CL, Hercus RG, Gullans SR, Sugarbaker DJ.

PLoS One. 2010 May 13;5(5):e10612. doi: 10.1371/journal.pone.0010612.

10.

Comparative effects of a novel plant-based calcium supplement with two common calcium salts on proliferation and mineralization in human osteoblast cells.

Adluri RS, Zhan L, Bagchi M, Maulik N, Maulik G.

Mol Cell Biochem. 2010 Jul;340(1-2):73-80. doi: 10.1007/s11010-010-0402-0. Epub 2010 Mar 7.

PMID:
20213262
11.

Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats.

Samuel SM, Thirunavukkarasu M, Penumathsa SV, Koneru S, Zhan L, Maulik G, Sudhakaran PR, Maulik N.

Circulation. 2010 Mar 16;121(10):1244-55. doi: 10.1161/CIRCULATIONAHA.109.872481. Epub 2010 Mar 1.

12.

Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.

Gordon GJ, Dong L, Yeap BY, Richards WG, Glickman JN, Edenfield H, Mani M, Colquitt R, Maulik G, Van Oss B, Sugarbaker DJ, Bueno R.

J Natl Cancer Inst. 2009 May 6;101(9):678-86. doi: 10.1093/jnci/djp061. Epub 2009 Apr 28.

13.

Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury.

Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Maulik G, Bagchi M, Bagchi D, Maulik N.

Biochim Biophys Acta. 2009 Jan;1792(1):39-48. doi: 10.1016/j.bbadis.2008.10.018. Epub 2008 Nov 5.

14.

Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor.

Penumathsa SV, Koneru S, Samuel SM, Maulik G, Bagchi D, Yet SF, Menon VP, Maulik N.

Free Radic Biol Med. 2008 Oct 1;45(7):1027-34. doi: 10.1016/j.freeradbiomed.2008.07.012. Epub 2008 Jul 27.

15.

White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt/FOXO3a/NFkappaB survival pathway.

Thirunavukkarasu M, Penumathsa SV, Samuel SM, Akita Y, Zhan L, Bertelli AA, Maulik G, Maulik N.

J Agric Food Chem. 2008 Aug 13;56(15):6733-9. doi: 10.1021/jf801473v. Epub 2008 Jul 19.

PMID:
18642840
16.

Transcriptome sequencing of malignant pleural mesothelioma tumors.

Sugarbaker DJ, Richards WG, Gordon GJ, Dong L, De Rienzo A, Maulik G, Glickman JN, Chirieac LR, Hartman ML, Taillon BE, Du L, Bouffard P, Kingsmore SF, Miller NA, Farmer AD, Jensen RV, Gullans SR, Bueno R.

Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3521-6. doi: 10.1073/pnas.0712399105. Epub 2008 Feb 26.

17.

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.

Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N.

J Cell Mol Med. 2008 Dec;12(6A):2350-61. doi: 10.1111/j.1582-4934.2008.00251.x. Erratum in: J Cell Mol Med. 2010 Oct;14(10):2539.

18.

Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis.

Thirunavukkarasu M, Addya S, Juhasz B, Pant R, Zhan L, Surrey S, Maulik G, Menon VP, Maulik N.

J Cell Mol Med. 2008 Aug;12(4):1284-302. doi: 10.1111/j.1582-4934.2008.00269.x. Epub 2008 Feb 8.

19.

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.

Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.

Cancer Chemother Pharmacol. 2008 Apr;61(4):549-58. Epub 2007 May 24.

PMID:
17522864
20.

Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4.

Koneru S, Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Han Z, Maulik G, Das DK, Maulik N.

Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2060-72. Epub 2007 Feb 2. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H891. Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H575.

21.

Common and contrasting genomic profiles among the major human lung cancer subtypes.

Tonon G, Brennan C, Protopopov A, Maulik G, Feng B, Zhang Y, Khatry DB, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Wong KK, Depinho RA.

Cold Spring Harb Symp Quant Biol. 2005;70:11-24.

PMID:
16869734
22.

Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast.

Mukhopadhyay NK, Gordon GJ, Maulik G, Doerre G, Liu BC, Bueno R, Sugarbaker DJ, Jaklitsch MT.

J Cell Mol Med. 2005 Jul-Sep;9(3):662-9.

23.

High-resolution genomic profiles of human lung cancer.

Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Depinho RA.

Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9625-30. Epub 2005 Jun 27.

24.

Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.

Maulik G, Bharti A, Khan E, Broderick RJ, Kijima T, Salgia R.

J Environ Pathol Toxicol Oncol. 2004;23(4):237-51.

PMID:
15511212
25.

Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.

Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT, Salgia R.

Anticancer Res. 2004 Mar-Apr;24(2C):1031-8.

26.

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R.

Cancer Res. 2003 Oct 1;63(19):6272-81.

27.

Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.

Jafri NF, Ma PC, Maulik G, Salgia R.

J Environ Pathol Toxicol Oncol. 2003;22(3):147-65. Review.

PMID:
14529091
28.
29.

c-Met: structure, functions and potential for therapeutic inhibition.

Ma PC, Maulik G, Christensen J, Salgia R.

Cancer Metastasis Rev. 2003 Dec;22(4):309-25. Review.

PMID:
12884908
30.

Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.

Maulik G, Madhiwala P, Brooks S, Ma PC, Kijima T, Tibaldi EV, Schaefer E, Parmar K, Salgia R.

J Cell Mol Med. 2002 Oct-Dec;6(4):539-53.

31.

Role of receptor tyrosine kinases in lung cancer.

Maulik G, Kijima T, Salgia R.

Methods Mol Med. 2003;74:113-25. Review.

PMID:
12415690
32.

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R.

Cancer Res. 2002 Nov 1;62(21):6304-11.

33.

Molecular alterations in lung cancer. Impact on prognosis.

Kijima T, Maulik G, Salgia R.

Methods Mol Med. 2003;75:29-38. Review.

PMID:
12407733
34.

Flow cytometric determination of lipid peroxidation using fluoresceinated phosphoethanolamine.

Maulik G, Salgia R, Makrigiorgos GM.

Methods Enzymol. 2002;352:80-91.

PMID:
12125379
35.

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R.

Clin Cancer Res. 2002 Feb;8(2):620-7.

36.

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.

Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R.

Cytokine Growth Factor Rev. 2002 Feb;13(1):41-59. Review.

PMID:
11750879
37.

Reproducible and inexpensive probe preparation for oligonucleotide arrays.

Zhang Y, Price BD, Tetradis S, Chakrabarti S, Maulik G, Makrigiorgos GM.

Nucleic Acids Res. 2001 Jul 1;29(13):E66-6.

38.

Highly selective isolation of unknown mutations in diverse DNA fragments: toward new multiplex screening in cancer.

Chakrabarti S, Price BD, Tetradis S, Fox EA, Zhang Y, Maulik G, Makrigiorgos GM.

Cancer Res. 2000 Jul 15;60(14):3732-7.

39.

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.

Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R.

Oncogene. 2000 Jul 20;19(31):3521-8.

40.

Myocardial protection with red wine extract.

Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A, Das DK.

J Cardiovasc Pharmacol. 2000 Feb;35(2):263-8.

PMID:
10672859
41.

Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin.

Sato M, Maulik G, Bagchi D, Das DK.

Free Radic Res. 2000 Feb;32(2):135-44.

PMID:
10653484
42.

Fever: an integrated response of the central nervous system to oxidative stress.

Riedel W, Maulik G.

Mol Cell Biochem. 1999 Jun;196(1-2):125-32.

PMID:
10448911
43.

The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury.

Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK.

Free Radic Biol Med. 1999 Jul;27(1-2):160-9.

PMID:
10443932
44.

Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury.

Sato M, Maulik G, Ray PS, Bagchi D, Das DK.

J Mol Cell Cardiol. 1999 Jun;31(6):1289-97.

PMID:
10371703
45.

Cardioprotection of red wine: role of polyphenolic antioxidants.

Das DK, Sato M, Ray PS, Maulik G, Engelman RM, Bertelli AA, Bertelli A.

Drugs Exp Clin Res. 1999;25(2-3):115-20. Review.

PMID:
10370873
46.

Novel non-isotopic detection of MutY enzyme-recognized mismatches in DNA via ultrasensitive detection of aldehydes.

Maulik G, Botchway S, Chakrabarti S, Tetradis S, Price B, Makrigiorgos GM.

Nucleic Acids Res. 1999 Mar 1;27(5):1316-22.

47.

Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia.

Maulik N, Tosaki A, Elliott GT, Maulik G, Das DK.

Drugs Exp Clin Res. 1998;24(3):117-24.

PMID:
9825227
48.

Fluoresceinated phosphoethanolamine for flow-cytometric measurement of lipid peroxidation.

Maulik G, Kassis AI, Savvides P, Makrigiorgos GM.

Free Radic Biol Med. 1998 Oct;25(6):645-53.

PMID:
9801063
49.

Detection of oxidative DNA damage to ischemic reperfused rat hearts by 8-hydroxydeoxyguanosine formation.

Cordis GA, Maulik G, Bagchi D, Riedel W, Das DK.

J Mol Cell Cardiol. 1998 Oct;30(10):1939-44.

PMID:
9799648
50.

Supplemental Content

Loading ...
Support Center